{
  "nodes": [
    {
      "id": "N1",
      "label": "Step 1",
      "customData": {
        "node_id": "A",
        "node_step_index": 0,
        "content": "44-year-old man diagnosed with NSCLC (cT4N2M0, stage IIIB) one year prior to admission due to persistent cough. Right lung tumor was discovered.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C0678222",
              "label": "Non-small cell lung carcinoma",
              "status": "historical",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N2",
      "label": "Step 2",
      "customData": {
        "node_id": "B",
        "node_step_index": 1,
        "content": "Patient underwent radiation therapy alone (60 Gy to primary tumor and adjacent mediastinal lymph nodes, 50 Gy to right hilum) after declining bronchoscopy for histological examination or chemotherapy.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Radiation therapy",
              "approach": "other",
              "date": null,
              "location": "primary tumor and adjacent mediastinal lymph nodes",
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N3",
      "label": "Step 3",
      "customData": {
        "node_id": "C",
        "node_step_index": 2,
        "content": "Eight months later, regrowth of the primary tumor in the right lung occurred, accompanied by intrapulmonary metastasis.",
        "clinical_data": {
          "diagnoses": [
            {
              "code": "C34.9",
              "label": "Malignant neoplasm of unspecified part of bronchus or lung",
              "status": "active",
              "onset_date": null
            },
            {
              "code": "C79.31",
              "label": "Secondary malignant neoplasm of right lung",
              "status": "active",
              "onset_date": null
            }
          ]
        }
      }
    },
    {
      "id": "N4",
      "label": "Step 4",
      "customData": {
        "node_id": "D",
        "node_step_index": 3,
        "content": "Transbronchial biopsy with bronchoscopy confirmed NSCLC diagnosis, with no mutations in epidermal growth factor receptor or anaplastic lymphoma kinase genes. Programmed cell death-ligand 1 staining tumor proportion score was >50%.",
        "clinical_data": {
          "procedures": [
            {
              "name": "Transbronchial biopsy",
              "approach": "endoscopic",
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            },
            {
              "name": "Bronchoscopy",
              "approach": "endoscopic",
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ],
          "diagnoses": [
            {
              "code": "C34",
              "label": "NSCLC",
              "status": "active",
              "onset_date": null
            }
          ],
          "labs": [
            {
              "test": "Programmed cell death-ligand 1 staining tumor proportion score",
              "value": ">50",
              "unit": "%",
              "flag": "abnormal",
              "reference_range": null,
              "timestamp": null
            }
          ]
        }
      }
    },
    {
      "id": "N5",
      "label": "Step 5",
      "customData": {
        "node_id": "E",
        "node_step_index": 4,
        "content": "Patient received three courses of chemotherapy: carboplatin (AUC 5) and paclitaxel (200 mg/m3) every three weeks.",
        "clinical_data": {
          "medications": [
            {
              "drug": "C0007127",
              "dosage": "AUC 5",
              "frequency": "every three weeks",
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "C0030393",
              "dosage": "200 mg/m3",
              "frequency": "every three weeks",
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "C0009372",
              "approach": null,
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N6",
      "label": "Step 6",
      "customData": {
        "node_id": "F",
        "node_step_index": 5,
        "content": "Pembrolizumab (200 mg/body) was added to the fourth course of chemotherapy one month before admission.",
        "clinical_data": {
          "medications": [
            {
              "drug": "Pembrolizumab",
              "dosage": "200 mg/body",
              "frequency": "with fourth course of chemotherapy",
              "modality": "IV",
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ]
        }
      }
    },
    {
      "id": "N7",
      "label": "Step 7",
      "customData": {
        "node_id": "G",
        "node_step_index": 6,
        "content": "On admission, body temperature was 36.8\u00b0C, and chest radiography showed no new lesions. Patient underwent the fifth course of immunochemotherapy as scheduled (pembrolizumab, carboplatin, paclitaxel).",
        "clinical_data": {
          "vitals": [
            {
              "type": "Body Temperature",
              "value": "36.8",
              "unit": "\u00b0C"
            }
          ],
          "imaging": [
            {
              "type": "Radiography",
              "body_part": "Chest",
              "modality": "X-ray",
              "finding": "no new lesions",
              "date": null
            }
          ],
          "medications": [
            {
              "drug": "pembrolizumab",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "carboplatin",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            },
            {
              "drug": "paclitaxel",
              "dosage": null,
              "frequency": null,
              "modality": null,
              "start_date": null,
              "end_date": null,
              "indication": null
            }
          ],
          "procedures": [
            {
              "name": "immunochemotherapy",
              "approach": null,
              "date": null,
              "location": null,
              "performed_by": null,
              "outcome": null
            }
          ]
        }
      }
    },
    {
      "id": "N8",
      "label": "Step 8",
      "customData": {
        "node_id": "H",
        "clinical_data": {}
      }
    }
  ],
  "edges": [
    {
      "from": "N1",
      "to": "N2",
      "data": {
        "edge_id": "A_to_B",
        "branch_flag": true,
        "content": "Patient declined bronchoscopy for histological examination or chemotherapy and underwent radiation therapy alone (60 Gy to primary tumor and adjacent mediastinal lymph nodes, 50 Gy to right hilum).",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0036341"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N2",
      "to": "N3",
      "data": {
        "edge_id": "B_to_C",
        "branch_flag": true,
        "content": "Eight months later, regrowth of the primary tumor in the right lung occurred, accompanied by intrapulmonary metastasis.",
        "transition_event": {
          "trigger_type": "progression",
          "trigger_entities": [
            "C0678222"
          ],
          "change_type": "progression",
          "target_domain": "diagnosis"
        }
      }
    },
    {
      "from": "N3",
      "to": "N4",
      "data": {
        "edge_id": "C_to_D",
        "branch_flag": true,
        "content": "Transbronchial biopsy with bronchoscopy confirmed NSCLC diagnosis, with no mutations in epidermal growth factor receptor or anaplastic lymphoma kinase genes. Programmed cell death-ligand 1 staining tumor proportion score was >50%.",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "C0006266",
            "C0006266"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N4",
      "to": "N5",
      "data": {
        "edge_id": "D_to_E",
        "branch_flag": true,
        "content": "Patient received three courses of chemotherapy: carboplatin (AUC 5) and paclitaxel (200 mg/m3) every three weeks.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "C0007127",
            "C0030393"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N5",
      "to": "N6",
      "data": {
        "edge_id": "E_to_F",
        "branch_flag": true,
        "content": "Pembrolizumab (200 mg/body) was added to the fourth course of chemotherapy one month before admission.",
        "transition_event": {
          "trigger_type": "medication_change",
          "trigger_entities": [
            "Pembrolizumab"
          ],
          "change_type": "addition",
          "target_domain": "medication"
        }
      }
    },
    {
      "from": "N6",
      "to": "N7",
      "data": {
        "edge_id": "F_to_G",
        "branch_flag": true,
        "content": "On admission, body temperature was 36.8\u00b0C, and chest radiography showed no new lesions. Patient underwent the fifth course of immunochemotherapy as scheduled (pembrolizumab, carboplatin, paclitaxel).",
        "transition_event": {
          "trigger_type": "procedure",
          "trigger_entities": [
            "immunochemotherapy"
          ],
          "change_type": "addition",
          "target_domain": "procedure"
        }
      }
    },
    {
      "from": "N7",
      "to": "N8",
      "data": {
        "edge_id": "G_to_H",
        "branch_flag": true,
        "content": "No new information provided."
      }
    }
  ]
}